358 related articles for article (PubMed ID: 20074973)
1. Does osteocytic SOST suppression mediate PTH bone anabolism?
Kramer I; Keller H; Leupin O; Kneissel M
Trends Endocrinol Metab; 2010 Apr; 21(4):237-44. PubMed ID: 20074973
[TBL] [Abstract][Full Text] [Related]
2. [Biological function of bone cells on the PTH-driven anabolic effect].
Hasegawa T; Hongo H; Sasaki M; Yamada T; Amizuka N
Clin Calcium; 2012 Mar; 22(3):373-9. PubMed ID: 22370304
[TBL] [Abstract][Full Text] [Related]
3. SOST is a target gene for PTH in bone.
Keller H; Kneissel M
Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
[TBL] [Abstract][Full Text] [Related]
4. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
[TBL] [Abstract][Full Text] [Related]
5. Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone.
Silvestrini G; Ballanti P; Leopizzi M; Sebastiani M; Berni S; Di Vito M; Bonucci E
J Mol Histol; 2007 Aug; 38(4):261-9. PubMed ID: 17549589
[TBL] [Abstract][Full Text] [Related]
6. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
Kobayashi T
Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
[TBL] [Abstract][Full Text] [Related]
7. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
[TBL] [Abstract][Full Text] [Related]
8. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone - a bone anabolic and catabolic agent.
Poole KE; Reeve J
Curr Opin Pharmacol; 2005 Dec; 5(6):612-7. PubMed ID: 16181808
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes.
Bellido T
J Musculoskelet Neuronal Interact; 2006; 6(4):358-9. PubMed ID: 17185824
[No Abstract] [Full Text] [Related]
12. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.
Li C; Wang W; Xie L; Luo X; Cao X; Wan M
Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.
Poole KE; van Bezooijen RL; Loveridge N; Hamersma H; Papapoulos SE; Löwik CW; Reeve J
FASEB J; 2005 Nov; 19(13):1842-4. PubMed ID: 16123173
[TBL] [Abstract][Full Text] [Related]
15. Intermittent PTH administration improves alveolar bone formation in type 1 diabetic rats with periodontitis.
Kim JH; Kim AR; Choi YH; Kim A; Sohn Y; Woo GH; Cha JH; Bak EJ; Yoo YJ
J Transl Med; 2018 Mar; 16(1):70. PubMed ID: 29544500
[TBL] [Abstract][Full Text] [Related]
16. Effects of histone deacetylase inhibitor Scriptaid and parathyroid hormone on osteocyte functions and metabolism.
Sun N; Uda Y; Azab E; Kochen A; Santos RNCE; Shi C; Kobayashi T; Wein MN; Divieti Pajevic P
J Biol Chem; 2019 Jun; 294(25):9722-9733. PubMed ID: 31068415
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
[TBL] [Abstract][Full Text] [Related]
18. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
[TBL] [Abstract][Full Text] [Related]
19. Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation.
Robinson JA; Susulic V; Liu YB; Taylor C; Hardenburg J; Gironda V; Zhao W; Kharode Y; McLarney S; Bai Y; Malone DP; Murrills R; Bex F
J Cell Biochem; 2006 Aug; 98(5):1203-20. PubMed ID: 16514668
[TBL] [Abstract][Full Text] [Related]
20. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
